Arena Pharmaceuticals

Arena doses first subject in ELEVATE UC 12 phase 3 trial of Etrasimod in ulcerative colitis
Arena doses first subject in ELEVATE UC 12 phase 3 trial of Etrasimod in ulcerative colitis
Pharmaceutical Business Review
Arena Pharmaceuticals
clinical trials
etrasimod
ulcerative colitis
Flag link:
Why Arena Pharmaceuticals' Q2 Results Don't Matter
Why Arena Pharmaceuticals' Q2 Results Don't Matter
Motley Fool
earnings
Arena Pharmaceuticals
Refinitiv
Flag link:
Only 1 Number Mattered in Arena Pharmaceuticals' Q3 Results -- and It Was Big
Only 1 Number Mattered in Arena Pharmaceuticals' Q3 Results -- and It Was Big
Motley Fool
Arena Pharmaceuticals
earnings
Flag link:
Arena Pharmaceuticals’ Selective CB2 Receptor Activator Drug Candidate Fights Pain in Irritable Bowel Syndrome
Arena Pharmaceuticals’ Selective CB2 Receptor Activator Drug Candidate Fights Pain in Irritable Bowel Syndrome
Xtalks
IBS
Arena Pharmaceuticals
cannabinoid type 2 receptors
Flag link:
Arena’s Comeback Continues with $800M Deal for Blood Disease Drug
Arena’s Comeback Continues with $800M Deal for Blood Disease Drug
Xconomy
Arena Pharmaceuticals
United Therapeutics
PAH
ralinepag
Flag link:
Arena 3 for 3 as Crohn’s drug meets proof-of-concept test
Arena 3 for 3 as Crohn’s drug meets proof-of-concept test
Fierce Biotech
Arena Pharmaceuticals
olorinab
Crohn's Disease
Flag link:
3 Biotech Stocks That Skyrocketed This Week
3 Biotech Stocks That Skyrocketed This Week
Motley Fool
biotech
Geron
imetelstat
Arena Pharmaceuticals
etrasimod
Heron Therapeutics
HTX-011
Flag link:
Arena Pharmaceuticals Takes Aim at Celgene
Arena Pharmaceuticals Takes Aim at Celgene
Motley Fool
Arena Pharmaceuticals
Celgene
etrasimod
ozanimod
ulcerative colitis
Flag link:
Here's Why Arena Pharmaceuticals, Inc. Surged Again on Wednesday
Here's Why Arena Pharmaceuticals, Inc. Surged Again on Wednesday
Motley Fool
Arena Pharmaceuticals
etrasimod
ulcerative colitis
Flag link:
Celgene's Future Growth Could Depend on a Competitor's Trial This Quarter
Celgene's Future Growth Could Depend on a Competitor's Trial This Quarter
Motley Fool
Celgene
etrasimod
ozanimod
Arena Pharmaceuticals
MS
multiple sclerois
Flag link:
Three Interviews From the J.P. Morgan Healthcare Conference
Three Interviews From the J.P. Morgan Healthcare Conference
Motley Fool
JPMHC 2018
Alnylam
Arena Pharmaceuticals
Spark Therapeutics
Flag link:
Here's What Lifted Arena Pharmaceuticals, Inc. Stock in September
Here's What Lifted Arena Pharmaceuticals, Inc. Stock in September
Motley Fool
Arena Pharmaceuticals
ralinepag
PAH
pulmonary arterial hypertension
Flag link:
Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
TheStreet.com
Arena Pharmaceuticals
ralinepag
PAH
pulmonary arterial hypertension
Flag link:
Arena takes a big step down the comeback trail with PhII success, shares rocket up
Arena takes a big step down the comeback trail with PhII success, shares rocket up
Endpoints
Arena Pharmaceuticals
PAH
clinical trials
pulmonary arterial hypertension
ralinepag
Flag link:
Here's Why Arena Pharmaceuticals Rose as Much as 18.3% Friday
Here's Why Arena Pharmaceuticals Rose as Much as 18.3% Friday
Motley Fool
Arena Pharmaceuticals
ralinepag
Belviq
Flag link:
Arena Pharmaceuticals beats 4Q profit forecasts
Arena Pharmaceuticals beats 4Q profit forecasts
Yahoo/AP
Arena Pharmaceuticals
earnings
Flag link:
Arena Turns Page On Belviq - Restructures Deal With Eisai
Arena Turns Page On Belviq - Restructures Deal With Eisai
Seeking Alpha
Arena Pharmaceuticals
Belviq
Eisai
Flag link:
Arena Pharmaceuticals reports 3Q loss
Arena Pharmaceuticals reports 3Q loss
Yahoo/AP
earnings
Arena Pharmaceuticals
Flag link:
Drug maker faces a shareholder suit for failing to tell the whole truth
Drug maker faces a shareholder suit for failing to tell the whole truth
Stat/Pharmalot
shareholders
Arena Pharmaceuticals
Belviq
Flag link:
Eisai Inc. and Arena Pharmaceuticals Announce Availability of Once-Daily BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets
Eisai Inc. and Arena Pharmaceuticals Announce Availability of Once-Daily BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets
Yahoo
Eisai
Arena Pharmaceuticals
Belviq XR
Flag link:

Pages